Search

everythinglearnresearchcommunity

for

Search:↓

The review suggests that a special cell-derived treatment shows promise for various skin conditions and hair growth but needs more research for confirmation.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

Understanding and treating hair disorders in different ethnic groups requires knowledge of specific hair care practices and hair characteristics.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

Almost all patients with chronic kidney disease not yet on dialysis have at least one skin problem.

Witch hazel-based hair products improved scalp irritation and were well-tolerated.

Spironolactone is effective for acne, hidradenitis suppurativa, female hair loss, and hirsutism but is underused in dermatology.

Nanoparticle-based drug delivery to hair follicles is more effective when tested under conditions that match skin behavior.

Platelet-rich plasma can increase hair density and may help treat some skin conditions, but it's costly, not FDA-approved, and needs more research.

5-Alpha Reductase Inhibitors are effective for male hair loss and some skin conditions, but their effectiveness in women and safety concerns require careful use.

Men with early balding should be checked for metabolic syndrome, as there's a link between the two.

Botox is effective for urinary incontinence, chronic migraines, and male pattern hair loss, and a new test for Botox antibodies is more humane.

Vitiligo affects overall health and self-esteem, needing more research and awareness.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Behavioral dermatology treats skin problems by considering both emotional and physical factors.

Extended-release divalproex is better tolerated and more effective for seizures and psychiatric symptoms than delayed-release divalproex, but doesn't reduce hair loss.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.

Finasteride improves hair growth and reduces hirsutism in women, but side effects and optimal dosages need further research.

Taking L-tryptophan supplements might cause a condition similar to scleroderma in some people, which can get better after stopping the supplement and starting corticosteroid therapy.

Childhood ptosis can vary from a minor cosmetic issue to a serious condition and may signal other health problems.

EtG in hair can help detect alcohol use but may be inaccurate in people with certain health conditions.

Dermatologists can help detect and manage eating disorders by recognizing skin changes.

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

Combining ciclosporin and simvastatin can cause severe kidney damage.

Scientists made a carbon-14 labeled version of a drug with a 48% yield and over 99% purity.

Herbal formula shows promise for hair loss treatment.

Many women with seborrheic dermatitis also have acne and diabetes, and should be checked for these conditions to help improve their quality of life.